Literature DB >> 22893073

Relationship of blood pressure and other factors to serial retinal arteriolar diameter measurements over time: the beaver dam eye study.

Ronald Klein1, Chelsea E Myers, Michael D Knudtson, Kristine E Lee, Ronald Gangnon, Tien Y Wong, Barbara E K Klein.   

Abstract

OBJECTIVE: To describe the relationship of blood pressure (BP), antihypertensive medication use, and other factors to serial measurements of retinal arteriolar diameters over time in the Beaver Dam Eye Study.
METHODS: Retinal arteriolar diameter was measured by computer-assisted methods and summarized as central retinal arteriolar equivalent (CRAE) in 4573 persons aged 43 to 99 years at 4 examinations (each separated by 5 years) during a 15-year period. Associations of CRAE with risk factors measured concurrently and 5 years previously were determined using multivariate analyses.
RESULTS: While adjusting for image quality, refraction, and lens status, age (per 10 years: β estimate, -0.73; P < .001), systolic BP (per 10 mm Hg: concurrent examination, -2.74; P < .001; previous examination, -1.75; P < .001), smoking status (smoker vs nonsmoker: concurrent examination, 4.29; P < .001; previous examination, 1.63; P = .004), body mass index (per category: concurrent examination, -0.51; P = .05; previous examination, -0.22; P = .44), and heavy alcohol consumption (drinking) (current vs past/never heavy drinker: concurrent examination, -2.54; P = .03; previous examination, -2.42; P = .02) were associated with CRAE. In the same model, there were significant interactions between concurrent and previous systolic BP (0.11; P = .003) and between concurrent and previous body mass index (0.12; P = .04). Use of calcium channel blockers at both the concurrent and past examination (vs neither examination, 1.59; P = .01), but not other classes of antihypertensive drugs, was associated with CRAE.
CONCLUSIONS: Retinal arteriolar diameter is independently associated with past and current systolic BP, calcium channel blocker use, smoking status, body mass index, and heavy drinking during 5-year intervals. The relationships with CRAE are stronger for concurrent than for past measures of these variables.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22893073      PMCID: PMC3514510          DOI: 10.1001/archophthalmol.2012.560

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  54 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Revised formulas for summarizing retinal vessel diameters.

Authors:  Michael D Knudtson; Kristine E Lee; Larry D Hubbard; Tien Yin Wong; Ronald Klein; Barbara E K Klein
Journal:  Curr Eye Res       Date:  2003-09       Impact factor: 2.424

3.  Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study.

Authors:  L D Hubbard; R J Brothers; W N King; L X Clegg; R Klein; L S Cooper; A R Sharrett; M D Davis; J Cai
Journal:  Ophthalmology       Date:  1999-12       Impact factor: 12.079

4.  Retinal vessel diameter as a clinical predictor of diabetic retinopathy progression: time to take out the measuring tape.

Authors:  Tien Yin Wong
Journal:  Arch Ophthalmol       Date:  2011-01

Review 5.  Vasodilatation, not hypotension, improves resistance vessel design during treatment of essential hypertension: a literature survey.

Authors:  K L Christensen; M J Mulvany
Journal:  J Hypertens       Date:  2001-06       Impact factor: 4.844

6.  Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study.

Authors:  T Y Wong; R Klein; D J Couper; L S Cooper; E Shahar; L D Hubbard; M R Wofford; A R Sharrett
Journal:  Lancet       Date:  2001-10-06       Impact factor: 79.321

7.  Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients.

Authors:  Ernesto L Schiffrin; Qian Pu; Jeong Bae Park
Journal:  Am J Hypertens       Date:  2002-02       Impact factor: 2.689

8.  Changes in visual acuity in a population over a 10-year period : The Beaver Dam Eye Study.

Authors:  R Klein; B E Klein; K E Lee; K J Cruickshanks; R J Chappell
Journal:  Ophthalmology       Date:  2001-10       Impact factor: 12.079

9.  Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study.

Authors:  Tien Yin Wong; Ronald Klein; A Richey Sharrett; Bruce B Duncan; David J Couper; James M Tielsch; Barbara E K Klein; Larry D Hubbard
Journal:  JAMA       Date:  2002-03-06       Impact factor: 56.272

10.  Relationships between age, blood pressure, and retinal vessel diameters in an older population.

Authors:  Harry Leung; Jie Jin Wang; Elena Rochtchina; Ava G Tan; Tien Y Wong; Ronald Klein; Larry D Hubbard; Paul Mitchell
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-07       Impact factor: 4.799

View more
  12 in total

1.  Recurrence of macular edema in eyes with branch retinal vein occlusion changes the diameter of unaffected retinal vessels.

Authors:  Jong Chan Im; Jae Pil Shin; In Taek Kim; Dong Ho Park
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-11-20       Impact factor: 3.117

2.  Association Between Blood Pressure and Retinal Vessel Diameters Among Police Officers in the US Northeast.

Authors:  Ja K Gu; Luenda E Charles; Ronald Klein; Lisa M Grady; Claudia C Ma; Penelope Allison; John M Violanti; Michael E Andrew
Journal:  J Occup Environ Med       Date:  2018-03       Impact factor: 2.162

Review 3.  Biomarkers of Diabetic Retinopathy.

Authors:  Daniel Shu Wei Ting; Kara-Anne Tan; Val Phua; Gavin Siew Wei Tan; Chee Wai Wong; Tien Yin Wong
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

4.  Concordance between SIVA, IVAN, and VAMPIRE Software Tools for Semi-Automated Analysis of Retinal Vessel Caliber.

Authors:  Thibaud Mautuit; Pierre Cunnac; Carol Y Cheung; Tien Y Wong; Stephen Hogg; Emanuele Trucco; Vincent Daien; Thomas J MacGillivray; José Labarère; Christophe Chiquet
Journal:  Diagnostics (Basel)       Date:  2022-05-25

5.  Retinopathy and progression of CKD: The CRIC study.

Authors:  Juan E Grunwald; Maxwell Pistilli; Gui-Shuang Ying; Ebenezer Daniel; Maureen G Maguire; Dawei Xie; Revell Whittock-Martin; Candace Parker Ostroff; Joan C Lo; Raymond R Townsend; Crystal A Gadegbeku; James P Lash; Jeffrey C Fink; Mahboob Rahman; Harold I Feldman; John W Kusek
Journal:  Clin J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 8.237

6.  Determinants of retinal venular diameter: the Beaver Dam Eye Study.

Authors:  Chelsea E Myers; Ronald Klein; Michael D Knudtson; Kristine E Lee; Ronald Gangnon; Tien Y Wong; Barbara E K Klein
Journal:  Ophthalmology       Date:  2012-08-20       Impact factor: 12.079

7.  Retinal Vessel Calibers in Predicting Long-Term Cardiovascular Outcomes: The Atherosclerosis Risk in Communities Study.

Authors:  Sara B Seidelmann; Brian Claggett; Paco E Bravo; Ankur Gupta; Hoshang Farhad; Barbara E Klein; Ronald Klein; Marcelo Di Carli; Scott D Solomon
Journal:  Circulation       Date:  2016-09-28       Impact factor: 29.690

8.  Retinal vessel diameter in bilateral glaucoma suspects: comparison between the eye converted to glaucoma and the contralateral non-converted eye.

Authors:  Eunjoo Yoo; Chungkwon Yoo; Tae-Eun Lee; Yong Yeon Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-06-02       Impact factor: 3.117

9.  Variability of measurement of retinal vessel diameters.

Authors:  Charles D McCanna; Chelsea E Myers; Minyoung Lee; Lorraine G Danforth; Emily L Moore; Stacy M Meuer; Ronald Klein; Barbara E K Klein
Journal:  Ophthalmic Epidemiol       Date:  2013-12       Impact factor: 1.648

10.  Association of ideal cardiovascular health metrics and retinal microvascular findings: the Atherosclerosis Risk in Communities Study.

Authors:  Ejovwoke R Ogagarue; Pamela L Lutsey; Ronald Klein; Barbara E Klein; Aaron R Folsom
Journal:  J Am Heart Assoc       Date:  2013-11-19       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.